Although the reduced inhibin/activin ratio observed during menopause is probably due to impaired synthesis of inhibin,(22) ovarian failure might be thought to result from mutations in INHA gene, which would lead to decreased inhibin concentration and, consequently, increased FSH levels. This evidence concerns the gene BRD2 and ovarian dysfunction.